FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today announced the availability of a new 7.5 centimeter length of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface.

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) is celebrating the 20 th anniversary of the introduction of the GORE® VIABAHN® Endoprosthesis, the market-leading stent-graft ...

December 11, 2006 — The US Food and Drug Administration (FDA) has approved a polytetrafluoroethylene-heparin vascular graft for use in the treatment of peripheral artery disease, a myocardial ...

W. L. Gore & Associates of Flagstaff has launched a new vascular graft for vascular access. Designed for early cannulation within 24 hours after implantation, the Gore Acuseal expands treatment ...

Please provide your email address to receive an email when new articles are posted on . W. L. Gore & Associates Inc. is acquiring InnAVasc Medical Inc., a medical technology company focused on ...

Blood vessel replacements (vascular grafts) are used today for hemodialysis blood access, trauma repair and cardiovascular reconstruction. The first synthetic vascular grafts (blood vessel ...

Dec 12 (Reuters) - C. R. Bard Inc. said a U.S. federal court found W. L. Gore & Associates Inc to have willfully infringed Bard's patent related to certain vascular grafts and stent-grafts. The jury, ...

Blood vessel replacements (vascular grafts) are used today for hemodialysis blood access, trauma repair and cardiovascular reconstruction The first synthetic vascular grafts (blood vessel replacements ...